Aside from initiating antiviral immune responses that could help purge the HIV reservoir in the long run, we observed that anti–IFN-α treatment helped mitigate the adverse health effects of treatment interruption, including anemia and weight loss. Here, IFNA2 is linked to anemia (phenotype).